Cited by 52Artificial Intelligence in Healthcare and EducationArtificial Intelligence in HealthcareMachine Learning in Healthcare

Artificial intelligence/machine learning in diabetes care

Open access
Singla, Rajiv, Singla, Ankush, Gupta, Yashdeep, Kalra, Sanjay·2019·Indian Journal of Endocrinology and Metabolism

Abstract

Artificial intelligence/Machine learning (AI/ML) is transforming all spheres of our life, including the healthcare system. Application of AI/ML has a potential to vastly enhance the reach of diabetes care thereby making it more efficient. The huge burden of diabetes cases in India represents a unique set of problems, and provides us with a unique opportunity in terms of potential availability of data. Harnessing this data using electronic medical records, by all physicians, can put India at the forefront of research in this area. Application of AI/ML would provide insights to our problems as well as may help us to devise tailor-made solutions for the same.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/ijem.ijem_228_19

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Applications of artificial intelligence (machine learning) algorithms have become increasingly popular in many medical domains, but the formulation of such algorithms for modeling the long-term progression of diabetes remains limited.

    “Although the applications of artificial intelligence (machine learning) algorithms have been become increasingly popular in manymedical domains, the formulation of such algorithms for modeling the long-term progression of diabetes remains limited (81).”

    From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [81]

    The discussion preceding TYPE 2 DIABETES MANAGEMENT says AI/ML is used for several diabetes-related tasks, and the TYPE 2 DIABETES MANAGEMENT section says published work on using it to optimize patient-level therapy is scant. Neither passage establishes that algorithms for modeling the long-term progression of diabetes are limited. The paper also describes healthcare adoption of AI/ML as slow, rather than establishing increasing popularity across medical domains; page numbers are unavailable in our copy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • AI plays an important role in predicting complications using basic clinical and biochemical patient data.

    “AI plays an important role in predicting complications using basic clinical and biochemical patient data”

    From Artificial intelligence based prediction models for individuals at risk of multiple diabetic complications: A systematic review of the literature (2022) · cites this paper as Singla et al., 2019

    The section labeled Abstract (page unavailable) says AI/ML is used to predict the risk of diabetes complications, including nephropathy and retinopathy. It does not specify that those predictions use basic clinical and biochemical patient data; the blood-glucose and HbA1c measures discussed under Type 2 Diabetes Management concern treatment decisions, not complication prediction. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Predicting the occurrence of different complications is a challenging task due to different risk factors, unbalanced data, and rapid changes.

    “but predicting the occurrence of different complications is a challenging task due to different risk factors, unbalanced data and rapid changes (Singla et al., 2019).”

    From Artificial intelligence based prediction models for individuals at risk of multiple diabetic complications: A systematic review of the literature (2022) · cites this paper as Singla et al., 2019

    The Abstract (page not specified) says AI/ML is used to predict the risk of complications such as nephropathy and retinopathy. The Type 2 Diabetes Management section discusses noisy data and individual factors in treatment decisions, but neither passage says complication prediction is challenging because of different risk factors, unbalanced data, or rapid changes. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 16 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [1]Artificial intelligence | Definition of artificial intelligence in English by Oxford Dictionaries Oxford Dictionaries | English Last accessed on 2019 May 31 Available from: https://en.oxforddictionaries.com/definition/artificial_intelligence

Cited by

Sorted by citations

Authors
Singla, R., Singla, A., Gupta, Y., & Kalra, S.
Affiliations
Kalpavriksh (IN)
Corresponding author
  • Singla, Rajiv
  • Singla, Ankush
Venue
Indian Journal of Endocrinology and Metabolism
Published
2019
Volume
23
Issue
4
Pages
495
ISSN
2230-8210 (ISSN-L)
OpenAlex
W2977381217
Cited by
52
References
16
Citations by year
2026: 4 · 2025: 10 · 2024: 9 · 2023: 12 · 2022: 11 · 2021: 2 · 2020: 3 · 2018: 1
FWCI
1.27
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Indian Journal of Endocrinology and Metabolism (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
  • Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
Keywords
artificial intelligence, machine learning, diabetes management, electronic health records, health information use, personalized treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review